pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['nsclc', 'sclc']
 in either case, it is clear that complete pathologic response is a surrogate for overall survival. io + ct neoadjuvant in nsclc is here to stay! 
Scientific Advisor - Oncology at Bristol Myers Squibb, Chile 🇨🇱. Father of family, so happy!